Corporate
Licensing & Collaboration
Mergers & Acquisitions
Venture Capital
ASHER RUBIN is co-leader of Sidley’s global Technology and Life Sciences Transactions practice. He advises publicly held and private companies across the life sciences life cycle, venture capital and private equity funds, and academic medical centers on transactional matters within all segments of the life sciences industry. Asher provides legal counsel and strategic advice on licensing, collaboration, joint venture, and merger and acquisition transactions. Additionally, Asher has extensive experience in capital raising, including venture capital financing, public financing, including IPOs, secondary offerings and PIPE transactions, and royalty based financing. Asher regularly advises public and private life sciences company boards of directors on matters related to corporate governance. He advises clients and has deal experience that includes the United States, Europe, Asia, and the Middle East.
Asher provides practical guidance to CEOs, CFOs, GCs, and other executives on their everyday legal matters, which include board governance, compensation, and employment matters. He regularly serves as a senior advisor to C-level executives and in-house counsel and as an outside general counsel for clients with limited in-house resources.
Asher is frequently recognized by his peers, as well as in numerous industry publications, including:
Prior to joining Sidley, Asher was a partner at another global law firm where he led the Life Sciences and Healthcare industry team for more than 10 years. Asher also served as in-house counsel and ultimately general counsel of a publicly traded, fully integrated pharmaceutical company.
